Adjusted multinomial logistic regression models of class membership at baseline in relation to participant characteristics (N = 432). by Carolin Oetzmann (11397968)

Subjects:

Trend of mental health-related services utilization between 2016 and 2022. by Fernanda Talarico (807333)

Subjects:

Comparison of mental health-related services utilization between the pre (2016–2019) and post (2020–2022) pandemic onset periods. by Fernanda Talarico (807333)

Subjects:

Trend of all service utilization for all conditions between 2016 and 2022. by Fernanda Talarico (807333)

Subjects:

Transition probabilities and class sizes for three-step LTA model (N = 432). by Carolin Oetzmann (11397968)

Subjects:

Image 6_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.tif by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”

Image 3_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.tif by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”

Image 1_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.tif by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”

Table 2_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.docx by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”

Table 4_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.docx by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”

Table 3_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.docx by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”

Table 1_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.docx by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”

Table 5_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.docx by Lili Deng (152262)

“…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”

Meta-analysis of VL group versus FFB group in mean arterial pressure after intubation. by Nana Guo (8595126)

Subjects:

Supplementary Material for: Abnormal Right Ventricular to Pulmonary Artery Coupling in Patients with End-Stage Kidney Disease and Normalization After Renal Transplantation: An Obse... by figshare admin karger (2628495)

“…Results: Patients with ESKD had significantly lower TAPSE/PASP ratio at baseline (1.02 (0.71 - 1.63) vs. 1.29 (1.09 - 1.96), p<0.001). …”

Image 6_Long-term trends in the burden of pulmonary arterial hypertension in China and worldwide: new insights based on GBD 2021.tif by Zhehao Xu (16853059)

“…Background<p>Pulmonary arterial hypertension (PAH) poses a significant health challenge globally, with China experiencing a notable increase in its burden. …”

Image 5_Long-term trends in the burden of pulmonary arterial hypertension in China and worldwide: new insights based on GBD 2021.tif by Zhehao Xu (16853059)

“…Background<p>Pulmonary arterial hypertension (PAH) poses a significant health challenge globally, with China experiencing a notable increase in its burden. …”

Image 2_Long-term trends in the burden of pulmonary arterial hypertension in China and worldwide: new insights based on GBD 2021.tif by Zhehao Xu (16853059)

“…Background<p>Pulmonary arterial hypertension (PAH) poses a significant health challenge globally, with China experiencing a notable increase in its burden. …”

Image 4_Long-term trends in the burden of pulmonary arterial hypertension in China and worldwide: new insights based on GBD 2021.png by Zhehao Xu (16853059)

“…Background<p>Pulmonary arterial hypertension (PAH) poses a significant health challenge globally, with China experiencing a notable increase in its burden. …”

Image 3_Long-term trends in the burden of pulmonary arterial hypertension in China and worldwide: new insights based on GBD 2021.tif by Zhehao Xu (16853059)

“…Background<p>Pulmonary arterial hypertension (PAH) poses a significant health challenge globally, with China experiencing a notable increase in its burden. …”